Ruth H. Palmer
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Construction and Expression Analysis of the bin 3xOllas Tool Line.
Journal: microPublication biology
Published: November 25, 2025
Novel activating SNRNP70-ALK fusion in congenital infant-type hemispheric glioma displays clinical response to lorlatinib: a case-report.
Journal: NPJ precision oncology
Published: July 10, 2025
Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions.
Journal: The Journal of pathology
Published: January 22, 2025
RUVBL1 and RUVBL2 are druggable MYC effector regulators in neuroblastoma cells.
Journal: iScience
Published: October 09, 2024
The Alk receptor tyrosine kinase regulates Sparkly, a novel activity regulating neuropeptide precursor in the Drosophila central nervous system.
Journal: eLife
Published: June 21, 2024
Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.
Journal: Cancer research communications
Published: June 20, 2024
AlkTango reveals a role for Jeb/Alk signaling in the Drosophila heart.
Journal: Cell communication and signaling : CCS
Published: April 25, 2024
Occurrence of cancer in Marfan syndrome: Report of two patients with neuroblastoma and review of the literature.
Journal: American journal of medical genetics. Part A
Published: January 23, 2024
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 28, 2023
Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth.
Journal: Cell death and differentiation
Published: October 01, 2023
Last Updated: 09/26/2026